Rock Springs Capital Management’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.5M | Hold |
|
|||||
|
2025
Q1 | $14.7M | Sell |
|
|||||
|
2024
Q4 | $30.9M | Buy |
|
|||||
|
2024
Q3 | $37.5M | Sell |
|
|||||
|
2024
Q2 | $51.8M | Buy |
|
|||||
|
2024
Q1 | $57.6M | Buy |
|
|||||
|
2023
Q4 | $38.5M | Buy |
|
|||||
|
2023
Q3 | $13.8M | Buy |
|
|||||
|
2023
Q2 | $14.3M | Buy |
|
|||||
|
2023
Q1 | $15.2M | Hold |
|
|||||
|
2022
Q4 | $18.8M | Sell |
|
|||||
|
2022
Q3 | $11.9M | Buy |
|
|||||
|
2022
Q2 | $9.04M | Buy |
|
|||||
|
2022
Q1 | $3.31M | Buy |
|